Record investment in dental AI
Pearl, developers of artificial intelligence-powered imaging technology, has raised $58 million in Series B funding, the largest investment of its kind yet.
The company says that its machine learning and computer vision tools solve a core challenge in dentistry: inconsistency in diagnostic accuracy.
Its AI serves as a real-time aid to help dentists read patient x-rays, deliver consistent, objective, and accurate diagnoses and clearly communicate findings to patients with precision, clarity and confidence.
In the field of healthcare, dentistry has become an AI standard-bearer
Ophir Tanz
Since receiving FDA clearance for AI software to help dental professionals detect multiple different pathologies and other conditions in x-rays, Pearl’s clinical AI has gained regulatory authorisations for chairside use in more than 120 countries and recognition.
The company plans to use the funding announced both to accelerate ongoing development of computer vision capabilities – including detection and tracking of disease in 3D and other imaging modalities – and introduce new AI tools to improve patient treatment planning, insurance claim approvals and dental education.
“In the field of healthcare, dentistry has become an AI standard-bearer, demonstrating the technology’s enormous utility and benefit in day-to-day patient care – and Pearl has led the AI charge in dentistry,”
said Ophir Tanz, founder and chief executive.